Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.
Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.
Atherosclerosis. 2019 Mar;282:176-182. doi: 10.1016/j.atherosclerosis.2018.09.019. Epub 2018 Sep 22.
Thrombocytopenia in scavenger receptor BI (SR-BI) knockout mice is suggested to result from augmented platelet clearance induced by elevated intracellular unesterified cholesterol (UC) levels. We hypothesize that SR-BI deficiency may also influence platelet production at the level of its precursor cell in the bone marrow, the megakaryocyte.
In this study, we compared megakaryopoiesis and platelet production in SR-BI knockout and wild-type mice.
In line with our hypothesis, megakaryocytes from SR-BI knockout mice exhibited UC accumulation while no accumulation of UC was detectable in wild-type megakaryocytes. Bone marrow expression of transcription factors involved in megakaryocyte maturation was induced, but megakaryocyte counts were unchanged in bone marrow of SR-BI knockout mice. Interestingly, we did find a striking 62% decrease (p < 0.01) in proplatelet production by SR-BI knockout megakaryocytes. SR-BI knockout mice displayed an impaired increase in circulating platelet concentrations and bone marrow megakaryocyte numbers upon thrombopoietin challenge. Importantly, megakaryocytes from normolipidemic bone marrow-specific SR-BI knockout mice exhibited a normal ability to produce proplatelets. Moreover, bone marrow-specific deletion of SR-BI did not impair the thrombopoietin response or induce thrombocytopenia, confirming that absence of megakaryocyte SR-BI does not underlie the thrombocytopenic phenotype in total body SR-BI knockout mice.
In conclusion, the elevation of plasma unesterified cholesterol levels impairs megakaryopoiesis and platelet production in SR-BI knockout mice. Our findings suggest that, in addition to an increased platelet clearance, a decrease in platelet production may also, in part, explain the thrombocytopenic phenotype associated with SR-BI deficiency in mice.
scavenger receptor BI(SR-BI)基因敲除小鼠的血小板减少被认为是由于细胞内未酯化胆固醇(UC)水平升高导致的血小板清除增加所致。我们假设 SR-BI 缺乏也可能影响骨髓中血小板前体细胞-巨核细胞的生成。
在这项研究中,我们比较了 SR-BI 基因敲除和野生型小鼠的巨核细胞生成和血小板生成。
与我们的假设一致,SR-BI 基因敲除小鼠的巨核细胞中出现 UC 蓄积,而野生型巨核细胞中则检测不到 UC 蓄积。参与巨核细胞成熟的转录因子在骨髓中的表达被诱导,但 SR-BI 基因敲除小鼠的骨髓巨核细胞计数没有变化。有趣的是,我们确实发现 SR-BI 基因敲除的巨核细胞产生的前血小板数量显著减少了 62%(p < 0.01)。SR-BI 基因敲除小鼠在血小板生成素刺激下表现出循环血小板浓度和骨髓巨核细胞数量增加受损。重要的是,来自正常脂质骨髓特异性 SR-BI 基因敲除小鼠的巨核细胞表现出正常的产生前血小板的能力。此外,骨髓特异性 SR-BI 缺失不会损害血小板生成素反应或诱导血小板减少症,证实了在全身 SR-BI 基因敲除小鼠中,巨核细胞 SR-BI 的缺失不是血小板减少表型的基础。
总之,血浆未酯化胆固醇水平的升高会损害 SR-BI 基因敲除小鼠的巨核细胞生成和血小板生成。我们的研究结果表明,除了增加血小板清除外,血小板生成减少也可能部分解释了与小鼠 SR-BI 缺乏相关的血小板减少表型。